Urinary Incontinence, Mixed
Conditions
Keywords
acupuncture, randomised controlled trial, sham acupuncture
Brief summary
The purpose of the study is to assess the efficacy and safety of electroacupuncture on mixed urinary incontinence among women.
Detailed description
After being informed about the study and potential risk, all patients giving written informed consent form will be undergo a 1-week screening period to determine eligibility for study entry. Eligible patients will be randomly assigned to one of the three groups 1) electroacupuncture group: electroacupuncture will be provided to patients at BL33, BL35 and SP6 for 3 time per week for 8 weeks; 2) sham electroacupuncture group: sham electroacupuncture will be provided to patients at sham acupoints to BL33, BL35 and SP6 for 3 time per week for 8 weeks.The follow-up time for the first two groups are 24 weeks and life style counselling will be provided once when receiving the first acupuncture treatment(contents are the same as the life style counselling group). 3) life style counselling group: life style advice will be provided to patients at enrolment with content on drinking, diet, weight control, lung disease, urinary track infection control, and etc. Patients in this group will be followed up for 20 weeks. Primary and secondary outcome will be measured at 4, 8, 20, 32 weeks, respectively.
Interventions
OTHERelectroacupuncture
same as described in experimental arm.
OTHERsham electroacupuncture
same as described in sham comparator.
BEHAVIORALlife style counselling
life style counselling to patients with mixed urinary incontinence contains advice on daily drinking, caffeine intake, diet, constipation, exercise, heavy lifting, lung disease, urinary track infection and etc.
Sponsors
Shaanxi Hospital of Traditional Chinese Medicine
The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
Hubei Hospital of Traditional Chinese Medicine
The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Shanghai University of Traditional Chinese Medicine
Second Affiliated Hospital of Heilongjiang University of Chinese Medicine
Guangdong Provincial Hospital of Traditional Chinese Medicine
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)
Masking description
The participants, investigator and outcome assessor will be masked. The care provider will be different from investigator and outcome assessor.
Intervention model description
Patients who sign the informed consent form and are eligible for the study entry at week 0 will be randomised to one of the three groups: electro-acupuncture group, sham electroacupuncture group and life style consultation group. The three group will be assessed in a paralleled manner, and patients in the first two groups will be treated 3 times per week for 8 weeks and followed up for 24 weeks, while patients in the third group will be provided with life style improvement information once and followed-up for 20 weeks.
Eligibility
Sex/Gender
FEMALE
Age
35 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
1. Patients are female and meet the diagnosis criteria of mixed urinary incontinence; 2. Patients are between age of 35 to 75 years old; 3. Positive in cough stress test; 4. Experience persistent urinary incontinence for at least 3 months, and at least one episode for each of stress and urgent urinary incontinence in 72 hours in baseline screening; and 5. Patients have signed informed consent form and are willing to participate the study voluntarily. Patients will be included if all above 5 items are met.
Exclusion criteria
1. Patients have simple stress urinary incontinence, simple urgent urinary incontinence, overflowing urinary incontinence and neurogenic bladder, etc.; 2. Patients have uncontrolled urinary tract infection with urinary pain and urge; 3. Patients have urogenital system tumours and/or pelvic organ tumours; 4. Patients have taken drugs for urinary incontinence treatment or drugs possibly affect the function of lower urinary tract, or received non-drug treatment for urinary incontinence (i.e. electrical stimulation, bladder training, pelvic floor muscle training, and etc.) in the past one month; 5. Patients have history of surgeries for urinary incontinence and/or pelvic floor organs, including hysterectomy; 6. Patients have pelvic organ prolapse ≥ II degree; 7. Patients have residual urine ≥ 100ml; 8. Patients have uncontrolled diabetes mellitus and severe hypertension; 9. Patients have diseases affecting lower urinary tract function, e.g. multiple sclerosis, Alzheimer's disease, Parkinson's disease, spinal cord injury, cauda equina injury and multiple system atrophy, etc.; 10. Patients have severe heart, lung, brain, liver, kidney and hematopoietic system diseases, mental disorders and cognitive dysfunction; 11. Patients are constrained or unable to complete movements like walking, going stairs up and down and running, etc.; 12. Patients have poor compliance; 13. Patients are at pregnancy, breastfeeding or postpartum period for less than 12 months; 14. Patients have cardiac pacemaker, metal allergy or strong fear of needle; 15. Patients are participants of other on-going studies; or 16. Patients have received acupuncture in the past 3 months. Patients will be excluded if they meet any of the above criteria.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| the proportion of participants with at least 50 percent decrease from baseline in the mean 24-hour incontinence episodes. | at the 8th week after the last treatment | data will be collected and evaluated by 72-hour incontinence episodes dairy |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| the proportion of participants with at least 50 percent decrease from baseline in the mean 24-hour urgent incontinence episodes | at baseline, 4th, 8th 20th and 32nd week | data will be collected and evaluated by 72-hour incontinence episodes dairy |
| the proportion of participants with at least 50 percent decrease from baseline in the mean 24-hour stress incontinence episodes | at baseline, 4th, 8th, 20th and 32nd week | data will be collected and evaluated by 72-hour incontinence episodes dairy |
| the change from baseline in the amount of urine leakage measured by the 1-hour pad test | at baseline, and the 8th week | data will be collected by 1-hour pad test |
| the change from baseline in the validated Chinese version of International Consultation on Incontinence Questionnaire-Short Form(ICIQ-SF) scores | at baseline, 4th, 8th, 20th and 32nd week | data will be collected via International Consultation on Incontinence Questionnaire-Short Form(ICIQ-SF). The total score(0-21scores) is an accumulated scores from question 1 to 3. The higher the total score is, the severer the incontinence is. |
| the proportion of participants with at least 50 percent decrease from baseline in the mean 24-hour incontinence episodes | at baseline, 4th, 20th and 32nd week | data will be collected and evaluated by 72-hour incontinence episodes dairy |
| number of patients with one or more life style change | at the 4th, 8th, 20th and 32nd week | life style change, such as drinking, diet, weight control and etc, will be evaluated through questionnaire |
| incidence rate of any adverse events | this is a case-based data reported by each centre from the start of treatment to the end of follow-up, up to 1 year and 4 months. | adverse event associated either with or without acupuncture will be documented as soon as it is reported in any centres. The type of conditions, time of on-set and relief, its relation with the intervention, treatment to the adverse event, whether the patient's participation is terminated or not due to the adverse event, etc. |
| patients' expectation to treatment | at baseline | patients will be asked about their expected effect of the treatment via question: In your expectation, how is your incontinence like in a two month time. Five choices will be provided 1) much better; 2) slightly better; 3) I don't know; 4) no change; 5) worse. |
| blinding assessment | in 8th week after any acupuncture treatment | patients will be asked whether they received electroacupuncture or sham acupuncture to assess the effect of blinding |
| the change from baseline in the validated Chinese version of the Overactive Bladder Questionnaire-Short Form scores | at baseline 4th, 8th, 20th and 32nd week | data will be collected via the Overactive Bladder Questionnaire-Short Form. The higher the total score is, the severer the condition is. |
Contacts
Primary ContactHuan Chen, MPH, MD
Backup ContactZhishun Liu, PhD,MD
Outcome results
None listed